Updated September 2026Three molecules, not twoPreventiveMD review
It carries orforglipron alongside the usual pair, and quotes both of those as all-in.
The verdict
PreventiveMD advertises semaglutide from $83 a month and tirzepatide from $97, both described as all-in, and it also lists orforglipron from $149 — a third molecule most sellers in this category do not carry at all.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Orforglipron · Semaglutide · Tirzepatide
- Form
- Injection
- States
- 36
- From
- $83/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
PreventiveMD sells compounded semaglutide and compounded tirzepatide by injection, quoting them on its homepage as low as $83 and $97 a month respectively and describing both figures as all-in. It also lists orforglipron from $149 against a separate $49 monthly membership on brand plans. Thirty-six states are served.
Who writes the prescription, and what do they see?
Treatment is arranged remotely and a prescription precedes dispensing. The homepage carries the figures and the all-in claim rather than a description of the clinical process behind them, and the brand pathway is described as running through an approved oral tablet dispensed by a manufacturer's own service.
Carrying three molecules is the unusual part. Orforglipron is an oral small-molecule agent rather than a peptide, and a seller offering it is offering a different route rather than another version of the same one. What that route costs here is stated, which is more than most sellers manage for the drugs they do carry.
What happens when the dose goes up?
What happens to either figure as the dose climbs is not published. As-low-as phrasing signals a bottom rung by construction, so a reader should treat $83 as an opening price and establish the ladder at the intake rather than after the first escalation.
What the price includes
The two as-low-as figures are among the lowest advertised anywhere in this category, and the all-in description is the claim doing the work — it says the number is not a medication rate with fees to follow. The $49 monthly membership applies to brand plans rather than to the compounded lines, so a reader on the $83 route should confirm which side of that line their plan falls, because the two are priced on different terms.
What it claims, and what it cites
The semaglutide and tirzepatide are compounded, prepared by a pharmacy rather than manufactured and reviewed as finished products, so neither is FDA-approved and neither is assessed for safety, efficacy or quality before dispensing. The orforglipron pathway is described as an approved tablet dispensed through a manufacturer's own service, which is a different regulatory footing and worth separating from the compounded lines.
Where it holds up, and where it does not
- Strength: Carries a third molecule most sellers do not
- Strength: Both compounded figures described as all-in
- Strength: Brand and compounded routes priced separately
- Limitation: As-low-as phrasing implies a bottom rung
- Limitation: A $49 membership applies on brand plans
- Limitation: Fourteen states are not served
What the evidence says about this kind of treatment
The assessment above is about PreventiveMD. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader interested in orforglipron, which most sellers in this category do not offer at all.
- Wrong for
- A reader who wants a single stated rate rather than an as-low-as figure with the ladder unpublished.
How PreventiveMD compares
| Seller | Who it suits | Go |
|---|---|---|
| Alan Meds | A reader starting on injectable semaglutide who wants a low rate that is stated to hold as the dose climbs. | See Alan Meds → |
| Zera Health | A reader who reads the dose qualifier before the figure, since the $129 line is described as low-dose rather than as the standing rate. | See Zera Health → |
| DoctorAdam | A reader weighing a tablet against an injection who wants the decision to be about the routine rather than the cost. | See DoctorAdam → |
More GLP-1 telehealth sellers reviews: CollectiveEmbodyEnhance MDEverSlimFidelity Medical ClinicHarper Meds
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What is orforglipron?
- An oral small-molecule GLP-1 agent rather than a peptide, which makes it a different route from the injections most of this category sells. PreventiveMD lists it from $149.
- Does the $49 membership apply to me?
- It is described as applying to brand plans rather than to the compounded lines, so which side of that your plan falls on is the thing to confirm before ordering.
- Is $83 what I would actually pay?
- It is quoted as low as $83 and described as all-in, which marks it as a bottom rung. What a higher dose costs is not published, so establish the ladder at the intake.
- Is PreventiveMD expensive compared with other GLP-1 telehealth sellers?
- PreventiveMD publishes a starting figure of $83/mo. Across the 32 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $139, which puts PreventiveMD below the median, toward the cheaper end. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.